Clinical Trial

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Name: Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study — clinical trial record (NCT07676565)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ATT1D

Recruiting

View on ClinicalTrials.gov →

Summary

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

Trial Details

NCT Number	NCT07676565
Lead Sponsor	Indiana University Collaborators: Jaeb Center for Health Research
Conditions	Type 1 Diabetes
Enrollment	300 participants
Start Date	2026-03-24
Primary Completion	2028-04 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-30